An organizational shake-up in France instituted to turn around ailing performance left earnings at homeopathy specialist Boiron down almost two-thirds in 2024.
The Messimy, France-based firm posted a drop in operating profit of 62.8% to €15.7m ($17.2m) for the 12 months as it racked up €20.5m in costs related to the reorganization. This project involves eliminating 145 jobs at its homeopathy operation in France along with a four distribution centers. Boiron said the cuts were necessary in light of a major decline in sales since the French government
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?